Newborn Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global newborn screening market size reached US$ 880.2 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,371.7 Million by 2027, exhibiting a growth rate (CAGR) of 7.79% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Newborn screening is a public healthcare initiative focusing on infant screening, parental education, appropriate follow-up, diagnostic testing, disease management, and continued evaluation. It targets diseases that can cause significant morbidity, mortality, and intellectual disability (ID). Some of these diseases included in the newborn screening tests are galactosemia, phenylketonuria (PKU), homocystinuria, hearing loss, sickle cell disease (SCD), biotinidase deficiency, maple syrup urine, congenital adrenal hyperplasia, and medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. Nowadays, public healthcare organizations across the globe are adopting new testing techniques, such as tandem mass spectrometry (MS/MS), to detect disorders associated with protein and fatty acid metabolism using blood samples.
Newborn Screening Market Trends:
The rising prevalence of congenital conditions among infants, along with increasing concerns among parents about the health of children, represents one of the significant factors influencing the market. Newborn screening relies on a specific set of laboratory evaluations and point-of-care examinations for early detection, diagnosis, and intervention of disorders. These disorders are genetic, metabolic, blood, or hormone-related, which are not immediately apparent after delivery and require practical intervention. This, coupled with the rising awareness about early diagnosis and improving diagnostic modalities, is propelling the growth of the market. Moreover, with the development of robust immunoassays and molecular diagnostics, disorders like primary hypothyroidism, cystic fibrosis (CF), and congenital toxoplasmosis are being targeted in several newborn screening tests. Apart from this, governing agencies of numerous countries are planning to mandate newborn screening programs due to increasing child morbidity and mortality, which is also contributing to market growth. Furthermore, the leading players are engaged in building strategic partnerships to ensure product sustainability, which is anticipated to create a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global newborn screening market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology and test type.
Breakup by Product:
Instruments
Reagents
Breakup by Technology:
Tandem Mass Spectrometry
Pulse Oximetry
Enzyme Based Assay
DNA Assay
Electrophoresis
Others
Breakup by Test Type:
Dry Blood Spot Test
CCHD
Hearing Screen
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Baebies Inc., Bio-RAD Laboratories Inc., Chromsystems Instruments & Chemicals GmbH, Danaher Corporation, Masimo Corporation, Medtronic plc, Natus Medical Incorporated, Perkinelmer Inc., RECIPE Chemicals + Instruments GmbH, Thermo Fisher Scientific Inc., Trivitron Healthcare and Waters Corporation.
Key Questions Answered in This Report:
How has the global newborn screening market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global newborn screening market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the test type?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global newborn screening market and who are the key players?
What is the degree of competition in the industry?
Newborn screening is a public healthcare initiative focusing on infant screening, parental education, appropriate follow-up, diagnostic testing, disease management, and continued evaluation. It targets diseases that can cause significant morbidity, mortality, and intellectual disability (ID). Some of these diseases included in the newborn screening tests are galactosemia, phenylketonuria (PKU), homocystinuria, hearing loss, sickle cell disease (SCD), biotinidase deficiency, maple syrup urine, congenital adrenal hyperplasia, and medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. Nowadays, public healthcare organizations across the globe are adopting new testing techniques, such as tandem mass spectrometry (MS/MS), to detect disorders associated with protein and fatty acid metabolism using blood samples.
Newborn Screening Market Trends:
The rising prevalence of congenital conditions among infants, along with increasing concerns among parents about the health of children, represents one of the significant factors influencing the market. Newborn screening relies on a specific set of laboratory evaluations and point-of-care examinations for early detection, diagnosis, and intervention of disorders. These disorders are genetic, metabolic, blood, or hormone-related, which are not immediately apparent after delivery and require practical intervention. This, coupled with the rising awareness about early diagnosis and improving diagnostic modalities, is propelling the growth of the market. Moreover, with the development of robust immunoassays and molecular diagnostics, disorders like primary hypothyroidism, cystic fibrosis (CF), and congenital toxoplasmosis are being targeted in several newborn screening tests. Apart from this, governing agencies of numerous countries are planning to mandate newborn screening programs due to increasing child morbidity and mortality, which is also contributing to market growth. Furthermore, the leading players are engaged in building strategic partnerships to ensure product sustainability, which is anticipated to create a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global newborn screening market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology and test type.
Breakup by Product:
Instruments
Reagents
Breakup by Technology:
Tandem Mass Spectrometry
Pulse Oximetry
Enzyme Based Assay
DNA Assay
Electrophoresis
Others
Breakup by Test Type:
Dry Blood Spot Test
CCHD
Hearing Screen
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Baebies Inc., Bio-RAD Laboratories Inc., Chromsystems Instruments & Chemicals GmbH, Danaher Corporation, Masimo Corporation, Medtronic plc, Natus Medical Incorporated, Perkinelmer Inc., RECIPE Chemicals + Instruments GmbH, Thermo Fisher Scientific Inc., Trivitron Healthcare and Waters Corporation.
Key Questions Answered in This Report:
How has the global newborn screening market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global newborn screening market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the test type?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global newborn screening market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL NEWBORN SCREENING MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Instruments
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Reagents
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1 Tandem Mass Spectrometry
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Pulse Oximetry
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Enzyme Based Assay
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 DNA Assay
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Electrophoresis
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY TEST TYPE
8.1 Dry Blood Spot Test
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 CCHD
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Hearing Screen
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Agilent Technologies Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Baebies Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bio-RAD Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Chromsystems Instruments & Chemicals GmbH
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Danaher Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Masimo Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Medtronic plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Natus Medical Incorporated
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Perkinelmer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 RECIPE Chemicals + Instruments GmbH
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Thermo Fisher Scientific Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Trivitron Healthcare
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.13 Waters Corporation
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL NEWBORN SCREENING MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Instruments
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Reagents
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1 Tandem Mass Spectrometry
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Pulse Oximetry
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Enzyme Based Assay
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 DNA Assay
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Electrophoresis
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY TEST TYPE
8.1 Dry Blood Spot Test
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 CCHD
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Hearing Screen
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Agilent Technologies Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Baebies Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bio-RAD Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Chromsystems Instruments & Chemicals GmbH
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Danaher Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Masimo Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Medtronic plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Natus Medical Incorporated
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Perkinelmer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 RECIPE Chemicals + Instruments GmbH
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Thermo Fisher Scientific Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Trivitron Healthcare
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.13 Waters Corporation
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Newborn Screening Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Newborn Screening Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Newborn Screening Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Newborn Screening Market Forecast: Breakup by Test Type (in Million US$), 2022-2027
Table 5: Global: Newborn Screening Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Newborn Screening Market: Competitive Structure
Table 7: Global: Newborn Screening Market: Key Players
Table 1: Global: Newborn Screening Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Newborn Screening Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Newborn Screening Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Newborn Screening Market Forecast: Breakup by Test Type (in Million US$), 2022-2027
Table 5: Global: Newborn Screening Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Newborn Screening Market: Competitive Structure
Table 7: Global: Newborn Screening Market: Key Players
LIST OF FIGURES
Figure 1: Global: Newborn Screening Market: Major Drivers and Challenges
Figure 2: Global: Newborn Screening Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Newborn Screening Market: Breakup by Product (in %), 2021
Figure 5: Global: Newborn Screening Market: Breakup by Technology (in %), 2021
Figure 6: Global: Newborn Screening Market: Breakup by Test Type (in %), 2021
Figure 7: Global: Newborn Screening Market: Breakup by Region (in %), 2021
Figure 8: Global: Newborn Screening (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Newborn Screening (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Newborn Screening (Reagents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Newborn Screening (Reagents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Newborn Screening (Tandem Mass Spectrometry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Newborn Screening (Tandem Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Newborn Screening (Pulse Oximetry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Newborn Screening (Pulse Oximetry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Newborn Screening (Enzyme Based Assay) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Newborn Screening (Enzyme Based Assay) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Newborn Screening (DNA Assay) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Newborn Screening (DNA Assay) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Newborn Screening (Electrophoresis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Newborn Screening (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Newborn Screening (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Newborn Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Newborn Screening (Dry Blood Spot Test) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Newborn Screening (Dry Blood Spot Test) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Newborn Screening (CCHD) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Newborn Screening (CCHD) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Newborn Screening (Hearing Screen) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Newborn Screening (Hearing Screen) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Newborn Screening Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Newborn Screening Industry: SWOT Analysis
Figure 80: Global: Newborn Screening Industry: Value Chain Analysis
Figure 81: Global: Newborn Screening Industry: Porter's Five Forces Analysis
Figure 1: Global: Newborn Screening Market: Major Drivers and Challenges
Figure 2: Global: Newborn Screening Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Newborn Screening Market: Breakup by Product (in %), 2021
Figure 5: Global: Newborn Screening Market: Breakup by Technology (in %), 2021
Figure 6: Global: Newborn Screening Market: Breakup by Test Type (in %), 2021
Figure 7: Global: Newborn Screening Market: Breakup by Region (in %), 2021
Figure 8: Global: Newborn Screening (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Newborn Screening (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Newborn Screening (Reagents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Newborn Screening (Reagents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Newborn Screening (Tandem Mass Spectrometry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Newborn Screening (Tandem Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Newborn Screening (Pulse Oximetry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Newborn Screening (Pulse Oximetry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Newborn Screening (Enzyme Based Assay) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Newborn Screening (Enzyme Based Assay) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Newborn Screening (DNA Assay) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Newborn Screening (DNA Assay) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Newborn Screening (Electrophoresis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Newborn Screening (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Newborn Screening (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Newborn Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Newborn Screening (Dry Blood Spot Test) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Newborn Screening (Dry Blood Spot Test) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Newborn Screening (CCHD) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Newborn Screening (CCHD) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Newborn Screening (Hearing Screen) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Newborn Screening (Hearing Screen) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Newborn Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Newborn Screening Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Newborn Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Newborn Screening Industry: SWOT Analysis
Figure 80: Global: Newborn Screening Industry: Value Chain Analysis
Figure 81: Global: Newborn Screening Industry: Porter's Five Forces Analysis
